Clinical Trial: Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Hearing Aid

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Evaluation of Efficacy and Patient Acceptance of Sound Amplifier Téo First, in Mild and Moderate Presbycusis Patient 60 Years of Age and Older, With no Previous Heari

Brief Summary:

A personal sound amplifying device (PASP) like Teo First is a wearable electronic product that is not intended to compensate for impaired hearing, but rather is intended for non-hearing impaired consumers to amplify sounds in the environment for a number of reasons, such as for recreational activities. Nevertheless, a lot of mild and moderate impaired hearing people don't want to buy and wear all day a real hearing aid.

The goal of our study is to evaluate the benefit of such a device for mild and moderate presbycusis patient 60 years of age and older, with no previous hearing aid.

Detailed Summary:
Sponsor: Centre Hospitalier Universitaire de Nice

Current Primary Outcome: Audiometric tests (pure tone and speech) in silence and noise, with and without Teofirst [ Time Frame: 7 to 15 days after the first use of Teofirst ]

Original Primary Outcome: Same as current

Current Secondary Outcome: audiometric and mental tests [ Time Frame: D7 to 15 and D 40 ]

Original Secondary Outcome: Same as current

Information By: Centre Hospitalier Universitaire de Nice

Dates:
Date Received: March 19, 2013
Date Started: April 2013
Date Completion:
Last Updated: July 28, 2014
Last Verified: March 2013